Rekombinanter Rituximab Antikörper
Kurzübersicht für Rekombinanter Rituximab Antikörper (ABIN7482277)
Target
Antikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Verwendungszweck
- Anti-Rituximab Antibody (MALS verified)
-
Produktmerkmale
- Anti-idiotypic Antibodies
-
Immunogen
- Anti-Rituximab Antibody (ABIN7482277) are expressed from human 293 cells (HEK293).
-
-
-
-
Applikationshinweise
- This antibody can be paired with other CD20 antibodies to detect CD20 in sandwich ELISA or LFA assay.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Lagerung
- -20 °C
-
-
- Rituximab
-
Substanzklasse
- Antibody
-
Hintergrund
- Rituxan is a genetically engineered chimeric murine/human monoclonal antibody directed against the CD20 antigen found on the surface of normal and malignant B lymphocytes. The antibody is an IgG1 kappa immunoglobulin containing murine light- and heavy-chain variable region sequences and human constant region sequences. Rituximab is composed of two heavy chains of 451 amino acids and two light chains of 213 amino acids, Anti-Rituximab Antibodies (RIB-Y35c) is the monoclonal antibody of Rituximab expressed with human HEK293 cells.
Target
-